FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2953804556> ?p ?o ?g. }

• W2953804556 endingPage "3177" @default.
• W2953804556 startingPage "3177" @default.
• W2953804556 abstract "Abstract Background: Gastric cancer is the fifth most common cancer worldwide and the third leading cause of cancer-related death, particularly in China. Signet-ring cell carcinoma (SRCC) has specific epidemiology and oncogenesis in gastric cancer. Mutations in KRAS are detected in many types of human tumors and have been proved to be associated with development and progression of cancer. In this study, we sought to explore the role of KRAS in signet-ring cell carcinoma. Patients and methods: Genomic data from 393 GC samples from The Cancer Genome Atlas (TCGA) was extracted to analyze mutation status of KRAS. Sanger sequencing for KRAS was applied in 234 FFPE SRCC patient samples. Immunohistochemical(IHC) and Fluorence in situ hybridization(FISH) were performed to detect KRAS expression level and KRAS amplification status in FFPE samples. Patients were evaluated in terms of survival and clinicopathological characteristics, as well as KRAS mutation and expression status in TCGA and in our cohort, respectively. We also explored KRAS mutation and expression level in 4 SRCC cell lines. Drug inhibition rate of MEK/mTOR inhibitors was evaluated by cell viability assay. Results: Thirty-one patients (0.079%) and thirty-seven GC patients (0.094%) in TCGA harbored point mutations and copy number variation (CNV), respectively. Patients with KRAS point mutations and CNV showed higher mRNA level compared to non-mutant cases (P = 0.003 and P &lt; 0.001). No survival difference was observed between KRAS different gene status in TCGA cohort. In our 234 in-house SRCC samples, 15 samples harbored KRAS mutations. We further did analysis on the 75 patients which had enough FFPE samples. Eight patients showed KRAS mutations and two patients showed KRAS amplification. The median overall survival (OS) was 12.5 months for patients with KRAS mutation, and 19.5 months for patients without KRAS mutation (P = 0.045). The majority of SRCC patients are positive with KRAS detected by IHC, which is higher than our intestinal cohort (80% vs 38.6%, P&lt;0.001). However, no difference of overall survival was observed between different KRAS expression level. We further explore the correlation between KRAS status and drug sensitivity in 4 SRCC cell lines. SNU601 and SNU668, which harbored KRAS mutation, were hypersensitive to MEK inhibition. However, mTOR inhibitor showed no preference on SRCC cell lines in terms of KRAS status. Conclusion: These data demonstrate the status of KRAS gene in SRCC and uncover the therapeutic potential for targeting of these tumors through MEK inhibition in SRCC. Citation Format: Nandie Wu, Ying Huang, Xiangshan Fan, Yang Yang, Qin Liu, Lixia Yu, Rafael Rosell, Baorui Liu, Jia Wei. KRAS gene status in gastric signet-ring cell carcinoma patients and act as biomarker of MEK inhibitor [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 3177." @default.
• W2953804556 created "2019-07-12" @default.
• W2953804556 creator A5004716187 @default.
• W2953804556 creator A5013653434 @default.
• W2953804556 creator A5025682608 @default.
• W2953804556 creator A5030428536 @default.
• W2953804556 creator A5044216882 @default.
• W2953804556 creator A5044887899 @default.
• W2953804556 creator A5049692788 @default.
• W2953804556 creator A5066197146 @default.
• W2953804556 creator A5071375088 @default.
• W2953804556 date "2019-07-01" @default.
• W2953804556 modified "2023-10-14" @default.
• W2953804556 title "Abstract 3177: KRAS gene status in gastric signet-ring cell carcinoma patients and act as biomarker of MEK inhibitor" @default.
• W2953804556 doi "https://doi.org/10.1158/1538-7445.am2019-3177" @default.
• W2953804556 hasPublicationYear "2019" @default.
• W2953804556 type Work @default.
• W2953804556 sameAs 2953804556 @default.
• W2953804556 citedByCount "0" @default.
• W2953804556 crossrefType "journal-article" @default.
• W2953804556 hasAuthorship W2953804556A5004716187 @default.
• W2953804556 hasAuthorship W2953804556A5013653434 @default.
• W2953804556 hasAuthorship W2953804556A5025682608 @default.
• W2953804556 hasAuthorship W2953804556A5030428536 @default.
• W2953804556 hasAuthorship W2953804556A5044216882 @default.
• W2953804556 hasAuthorship W2953804556A5044887899 @default.
• W2953804556 hasAuthorship W2953804556A5049692788 @default.
• W2953804556 hasAuthorship W2953804556A5066197146 @default.
• W2953804556 hasAuthorship W2953804556A5071375088 @default.
• W2953804556 hasConcept C121608353 @default.
• W2953804556 hasConcept C126322002 @default.
• W2953804556 hasConcept C143998085 @default.
• W2953804556 hasConcept C189528381 @default.
• W2953804556 hasConcept C2780238495 @default.
• W2953804556 hasConcept C2781182431 @default.
• W2953804556 hasConcept C2781187634 @default.
• W2953804556 hasConcept C2781197716 @default.
• W2953804556 hasConcept C502942594 @default.
• W2953804556 hasConcept C526805850 @default.
• W2953804556 hasConcept C54355233 @default.
• W2953804556 hasConcept C71924100 @default.
• W2953804556 hasConcept C86803240 @default.
• W2953804556 hasConceptScore W2953804556C121608353 @default.
• W2953804556 hasConceptScore W2953804556C126322002 @default.
• W2953804556 hasConceptScore W2953804556C143998085 @default.
• W2953804556 hasConceptScore W2953804556C189528381 @default.
• W2953804556 hasConceptScore W2953804556C2780238495 @default.
• W2953804556 hasConceptScore W2953804556C2781182431 @default.
• W2953804556 hasConceptScore W2953804556C2781187634 @default.
• W2953804556 hasConceptScore W2953804556C2781197716 @default.
• W2953804556 hasConceptScore W2953804556C502942594 @default.
• W2953804556 hasConceptScore W2953804556C526805850 @default.
• W2953804556 hasConceptScore W2953804556C54355233 @default.
• W2953804556 hasConceptScore W2953804556C71924100 @default.
• W2953804556 hasConceptScore W2953804556C86803240 @default.
• W2953804556 hasIssue "13_Supplement" @default.
• W2953804556 hasLocation W29538045561 @default.
• W2953804556 hasOpenAccess W2953804556 @default.
• W2953804556 hasPrimaryLocation W29538045561 @default.
• W2953804556 hasRelatedWork W2023609916 @default.
• W2953804556 hasRelatedWork W2368630167 @default.
• W2953804556 hasRelatedWork W2392430486 @default.
• W2953804556 hasRelatedWork W2897259667 @default.
• W2953804556 hasRelatedWork W2953804556 @default.
• W2953804556 hasRelatedWork W2965006825 @default.
• W2953804556 hasRelatedWork W2969187635 @default.
• W2953804556 hasRelatedWork W3165262345 @default.
• W2953804556 hasRelatedWork W4214858636 @default.
• W2953804556 hasRelatedWork W4311092878 @default.
• W2953804556 hasVolume "79" @default.
• W2953804556 isParatext "false" @default.
• W2953804556 isRetracted "false" @default.
• W2953804556 magId "2953804556" @default.
• W2953804556 workType "article" @default.